Two Sigma Advisers’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-124,000
| Closed | -$40.4K | – | 2637 |
|
|
2023
Q2 | $40.4K | Sell |
124,000
-20,900
| -14% | -$6.81K | ﹤0.01% | 2285 |
|
|
2023
Q1 | $62.3K | Sell |
144,900
-41,100
| -22% | -$17.7K | ﹤0.01% | 2430 |
|
|
2022
Q4 | $98.6K | Sell |
186,000
-11,600
| -6% | -$6.15K | ﹤0.01% | 2300 |
|
|
2022
Q3 | $145K | Buy |
197,600
+1,500
| +0.8% | +$1.1K | ﹤0.01% | 2259 |
|
|
2022
Q2 | $224K | Buy |
196,100
+54,500
| +38% | +$62.3K | ﹤0.01% | 2242 |
|
|
2022
Q1 | $290K | Buy |
141,600
+34,100
| +32% | +$69.8K | ﹤0.01% | 2235 |
|
|
2021
Q4 | $310K | Sell |
107,500
-67,800
| -39% | -$196K | ﹤0.01% | 2131 |
|
|
2021
Q3 | $743K | Buy |
175,300
+46,700
| +36% | +$198K | ﹤0.01% | 1752 |
|
|
2021
Q2 | $680K | Sell |
128,600
-39,300
| -23% | -$208K | ﹤0.01% | 1807 |
|
|
2021
Q1 | $781K | Buy |
+167,900
| New | +$781K | ﹤0.01% | 1794 |
|